Ireland· IE-PA-PA0711/289/003
Sunitinib Rowex 50 mg hard capsules
A sunitinib product containing sunitinib, registered in Ireland by Rowex Limited,. The same ATC class is registered in 2 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Sunitinib is registered in 2 of 19 countries.
Countries holding a registration under ATC L01XE04 (sunitinib), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 1 of them publish a price we can compare per daily dose
Sunitinib · ATC L01XE04
2 / 19 countries
- Ireland
- Polandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Sunitinib
- Manufacturer
- Rowex Limited,
- Country
- Ireland (IE)
- ATC code
- L01XE04
- ATC class
- Sunitinib
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA0711/289/003
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
509 interactions on record for sunitinib.
Graded by severity as the source publishes them — 99 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sunitinib · interactions on record
509 records
- 99 severe
- 362 moderate
- 3 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
45 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Sunitinib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSUNITINIB ACCORDAccord Healthcare S.L.U., Barcelona
- NetherlandsEgotux 50 mg harde capsulesGenepharm S.A.
- PolandKlertisEgis Pharmaceuticals PLC
- SpainSUNITINIB ACCORD 50 mg CAPSULAS DURAS EFGAccord Healthcare S.L.U.
- SwedenSunitinib Accord 50 mg Kapsel, hårdAccord Healthcare S.L.U.
- FranceSUNITINIB ACCORD 50 mg, géluleACCORD HEALTHCARE (ESPAGNE)
- United KingdomSunitinib 50mg capsulesZentiva Pharma UK Ltd
- FinlandSunitinib AccordAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Sunitinib Bluefish, Sunitinib G.L.
- Belgium · Sunitinib Sandoz, Sunitinib Teva
- Bulgaria · Суганет, Сунитиниб Алкалоид-Инт
- Cyprus · Sunitinib Msn, Sunitinib Sapiens
- Czechia · Sunitinib Pharmagen, Sunitinib Sandoz
- Germany · Sunitinib Al, Sunitinib Aqvida
- Denmark · Sunitinib Medical Valley, Sunitinib Sandoz
- Estonia · Sunitinib Sandoz, Sunitinib Teva
- Spain · Sunitinib Bluepharma Indústria, Sunitinib Dr. Reddys
- Finland · Sunitinib Ratiopharm, Sunitinib Sandoz
- France · Sunitinib Arrow, Sunitinib Biogaran
- United Kingdom (Northern Ireland) · Sunitinib Amarox, Sunitinib Dr. Reddy’s
- Greece · Egotux, Sunidem
- Croatia · Sunitinib Alkaloid-Int, Sunitinib Be Pharma
- Hungary · Klertis, Suganet
- Iceland · Sunitinib Accord, Sunitinib Demo
- Italy · Sunitinib Aurobindo, Sunitinib Dr. Reddy’s
- Liechtenstein · Sunitinib Accord, Sutent
- Lithuania · Klertis, Sunitinib G.L. Pharma
- Luxembourg · Sunitinib Eg, Sunitinib Teva
- Latvia · Sunitinib Be Pharma, Sunitinib G.L. Pharma
- Malta · Sunitinib Dr. Reddy’s, Sunitinib Medichem
- Netherlands · Egotux, Klertis
- Norway · Sunitinib Accord, Sunitinib Medical Valley
- Poland · Klertis, Sunitinib Bluefish
- Portugal · Sunitinib Bluepharma, Sunitinib Bluepharma Indústria
- Romania · Klertis, Sunitinib Alkaloid-Int
- Sweden · Sunitinib Bluefish, Sunitinib Eugia
- Slovenia · Sunitinib Alkaloid-Int, Sunitinib Msn
- Slovakia · Klertis, Sunitinib G.L. Pharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eb2b6718-42dc-4c7c-90c2-f532e37784ce GET /v1/drugs/eb2b6718-42dc-4c7c-90c2-f532e37784ce?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"L01XE",
"L01XE04"
],
"strength": null,
"pa_number": "PA0711/289/003",
"substances": [
"Sunitinib"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "03/05/2019",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": "IC0147-023-001"
}See everything about sunitinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.